5I2X

Crystal Structure of TPP1 K170del

5I2X の概要

• エントリーDOI: 10.2210/pdb5i2x/pdb
• 関連するPDBエントリー: 2I46 5I2Y
• 分子名称: Adrenocortical dysplasia protein homolog (2 entities in total)
• 機能のキーワード: ob fold, protein binding
• 由来する生物種: Homo sapiens (Human)
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 34858.71

構造登録者

Nandakumar, J.,Smith, E. (登録日: 2016-02-09, 公開日: 2016-11-09, 最終更新日: 2023-09-27)

主引用文献

Bisht, K.,Smith, E.M.,Tesmer, V.M.,Nandakumar, J.
Structural and functional consequences of a disease mutation in the telomere protein TPP1.
Proc.Natl.Acad.Sci.USA, 113:13021-13026, 2016

PubMed Abstract: Telomerase replicates chromosome ends to facilitate continued cell division. Mutations that compromise telomerase function result in stem cell failure diseases, such as dyskeratosis congenita (DC). One such mutation (K170Δ), residing in the telomerase-recruitment factor TPP1, provides an excellent opportunity to structurally, biochemically, and genetically dissect the mechanism of such diseases. We show through site-directed mutagenesis and X-ray crystallography that this TPP1 disease mutation deforms the conformation of two critical amino acids of the TEL [TPP1's glutamate (E) and leucine-rich (L)] patch, the surface of TPP1 that binds telomerase. Using CRISPR-Cas9 technology, we demonstrate that introduction of this mutation in a heterozygous manner is sufficient to shorten telomeres in human cells. Our findings rule out dominant-negative effects of the mutation. Instead, these findings implicate reduced TEL patch dosage in causing telomere shortening. Our studies provide mechanistic insight into telomerase-deficiency diseases and encourage the development of gene therapies to counter such diseases.

PubMed: 27807141
DOI: 10.1073/pnas.1605685113

実験手法

X-RAY DIFFRACTION (3 Å)